Zeke Capital Advisors’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $15.3K | Sell |
433
-750
| -63% | -$26.6K | ﹤0.01% | 471 |
|
|
2022
Q3 | $267K | Hold |
1,183
| – | – | 0.02% | 346 |
|
|
2022
Q2 | $224K | Hold |
1,183
| – | – | 0.01% | 415 |
|
|
2022
Q1 | $295K | Hold |
1,183
| – | – | 0.01% | 376 |
|
|
2021
Q4 | $184K | Hold |
1,183
| – | – | 0.01% | 290 |
|
|
2021
Q3 | $237K | Hold |
1,183
| – | – | 0.01% | 256 |
|
|
2021
Q2 | $302K | Buy |
1,183
+83
| +8% | +$21.2K | 0.02% | 223 |
|
|
2021
Q1 | $292K | Hold |
1,100
| – | – | 0.02% | 206 |
|
|
2020
Q4 | $406K | Hold |
1,100
| – | – | 0.03% | 144 |
|
|
2020
Q3 | $269K | Buy |
+1,100
| New | +$269K | 0.03% | 173 |
|